Christopher Johnson on Muck Rack

Christopher Johnson

Verified
London
As seen in: Morningstar, Oracle, Morningstar UK, Citywire, Citywire Americas, Citywire Asia, Citywire Deutschland, Citywire Middle East, Citywire New Model Adviser, Citywire Pro Buyer, Citywire RIA and
Data Journalist @uk_morningstar | @Headlinemoney_ Rising Star B2B Journalist 2022 | Previously: @Citywire, @cnni, @TRF_Stories & @AJEnglish | Global Citizen
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Christopher

Contact Christopher, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Stock of the Week: Is AstraZeneca a Buy After Share Price Jump?

|
By Christopher Johnson Verified
| Morningstar
Pharmaceutical giant AstraZeneca AZN is making a big play for US investors, and some say, turning its back on Britain. Will the bid for American dollars – and its pipeline of drugs - boost AstraZeneca’s stock? AstraZeneca recently raised eyebrows – and its stock price - when it an announced it will list shares directly on the New York Stock Exchange. Since the news of the listing plan, AstraZeneca stock has jumped 16% and its shares are now up 24% this year.
Open in Who Shared Issue with article?

Is London Stock Exchange Group a Buy After Share Price Slump?

|
By Christopher Johnson Verified
| Morningstar
Despite a year over year rise in London Stock Exchange Group’s income and profits, its stock price has fallen 25%. LSEG is facing competition from new AI models and rivals like Bloomberg. Recent negative news about listings and IPOs includes a possible move by AstraZeneca from London to the New York Stock Exchange. The London Stock Exchange Group’s LSEG share price has fallen by a quarter this year, making the stock one of the worst performers in the UK market in Q3.
Open in Who Shared Issue with article?

Is London Stock Exchange Group a Buy After Share Price Slump?

|
By Christopher Johnson Verified
| Morningstar
Despite a year over year rise in London Stock Exchange Group’s income and profits, its stock price has fallen 25%. LSEG is facing competition from new AI models and rivals like Bloomberg. Recent negative news about listings and IPOs includes a possible move by AstraZeneca from London to the New York Stock Exchange. The London Stock Exchange Group’s LSEG share price has fallen by a quarter this year, making the stock one of the worst performers in the UK market in Q3.
Open in Who Shared Issue with article?
See all 59 licensed articles (1,007 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified